.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Merck
Chubb
Moodys
Cerilliant
Covington
Chinese Patent Office
US Army
Citi
Julphar

Generated: November 18, 2017

DrugPatentWatch Database Preview

TOLAZAMIDE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tolazamide and what is the scope of tolazamide patent protection?

Tolazamide
is the generic ingredient in two branded drugs marketed by Pharmacia And Upjohn, Watson Labs, Sandoz, Usl Pharma, Sun Pharm Inds, Mylan Pharms Inc, Par Pharm, Barr, Superpharm, Duramed Pharms Barr, Interpharm, and G And W Labs Inc, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for tolazamide. Two suppliers are listed for this compound.

Pharmacology for TOLAZAMIDE

Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea

Medical Subject Heading (MeSH) Categories for TOLAZAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
TOLAZAMIDE
tolazamide
TABLET;ORAL070160-001Jan 6, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Superpharm
TOLAZAMIDE
tolazamide
TABLET;ORAL070763-001Jun 16, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
TOLAZAMIDE
tolazamide
TABLET;ORAL071359-001Jul 16, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Duramed Pharms Barr
TOLAZAMIDE
tolazamide
TABLET;ORAL070165-001Jan 10, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Duramed Pharms Barr
TOLAZAMIDE
tolazamide
TABLET;ORAL070167-001Jan 10, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
TOLINASE
tolazamide
TABLET;ORAL015500-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Watson Labs
TOLAZAMIDE
tolazamide
TABLET;ORAL070515-001Jan 9, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
TOLINASE
tolazamide
TABLET;ORAL015500-005Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
G And W Labs Inc
TOLAZAMIDE
tolazamide
TABLET;ORAL018894-001Nov 2, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Barr
TOLAZAMIDE
tolazamide
TABLET;ORAL070164-001Jan 14, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Dow
Baxter
Healthtrust
Cantor Fitzgerald
Mallinckrodt
UBS
Merck
US Department of Justice
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot